1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Hepatitis C Therapies: World Industry, R&D and Market Forecasts 2015-2025

  • December 2014
  • 196 pages
  • Visiongain
Report ID: 2655179

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Hepatitis C treatments – your guide to medical needs, R&D trends and future drug revenues
Discover the future of treating hepatitis C virus (HCV). Now you can get sales forecasts and explore that industry’s research and development. See where the money lies from 2014. And find where that technology heads.

Visiongain’s new guide predicts those revenues to 2025 at overall world, submarket, product and national level. Its purpose is to help you stay ahead in data, news and analysis on those therapies. It examines medical, technological and commercial potentials and opportunities.

Can that that large, profitable market sustain revenue growth? Please read on to explore HCV medicines and their producers, seeing how high that industry’s sales can go.

Forecasts and other analyses to help your research, knowledge and influence
Avoid struggles to find business information on that viral infection. Instead discover what’s happening in technology and demand for therapy. With our investigation you can make your research, appraisals and commercial decisions on hepatitis C treatments quicker and easier.
- Who is the company with the highest expected revenue from 2015 to 2025?
- What technologies give the most promising candidates for new drugs?
- Where lie the best geographical opportunities for selling those antivirals?
- Why will the HCV drug market expand, and what limits its sales growth?
- When will that industry achieve fastest expansion and peak revenues?
- How will companies overcome challenges in serving regulators, patients and payers?

Besides sales predictions to 2025, our study presents recent results, growth rates, market shares and discussions. You get 69 tables, 53 charts and two interviews with authorities.

Forecasting of the world HCV therapy market and its segments
Our report predicts overall world revenue to 2025 for those anti-infective drugs. There you also find individual revenue predictions to 2025 for two submarkets at world level:
- Oral antiviral agents
- Interferons for treating that disorder.

For treating that infectious disease, especially of the liver, discover how competition and technological advances shape the industry. So benefit your reputation for commercial knowledge. And find where the most money and best prospects for commercial growth exist.

Also assess leading pharmaceutical brands for tackling those chronic infections.

Forecasts for HCV medicines – see potentials for top brands
How will six leading and three emerging drugs perform to 2025 at world level? Our study forecasts individual revenues of nine agents:
- Sovaldi (sofosbuvir)
- Olysio (simeprevir)
- Pegasys (peginterferon alfa-2a)
- Incivek and related brands (telaprevir)
- PegIntron (peginterferon alfa-2b)
- Victrelis (boceprevir)
- Harvoni (ledipasvir and sofosbuvir)
- Daklinza (daclatasvir)
- Sunvepra (asunaprevir).

Those analyses show you how high sales can go. There find products and years with highest predicted expansion and revenues. You hear what’s happening. And you deepen your understanding of trends, competition, challenges and opportunities.

In that work you also find national revenue predictions.

Healthcare in regional markets – what outlooks for that business?
Our investigation also shows you individual revenue forecasts to 2025 for 11 countries:
- United States (US)
- Japan
- Germany, France, UK, Italy and Spain (EU5 group)
- Brazil, Russia, India and China (BRIC nations).

There you find countries with highest revenues, demand and potential sales. Explore progress, needs and opportunities, seeing how you can gain.

And how do changes, challenges and technological advances affect that industry and market?

Forces, events and issues – developments influencing those antiviral treatments

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cirrhosis Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • June 2017
  • by GlobalData

Cirrhosis Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Cirrhosis Global Clinical Trials Review, H1, 2017" provides an overview of Cirrhosis clinical trials scenario. ...

Chronic Liver Disease Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • June 2017
  • by GlobalData

Chronic Liver Disease Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Liver Disease Global Clinical Trials Review, H1, 2017" provides an overview of Chronic ...

Global Biosimilars and Follow-On Biologics Market 2017-2027

  • $ 3247
  • Industry report
  • May 2017
  • by Visiongain

Report Details The global biosimilars and follow-on biologics market is expected to grow at a CAGR of 38.8% in the first half of the forecast period and CAGR of 11.3% in the second half of the forecast ...


Download Unlimited Documents from Trusted Public Sources

Hepatitis Treatment Market in China

  • July 2017
    38 pages
  • Hepatitis Treat...  

    Antiviral  

    Pharmaceutical  

  • China  

    Asia  

View report >

Global Hepatitis Statistics and Vaccine Market

  • July 2017
    62 pages
  • Hepatitis  

    Vaccine  

  • World  

    United States  

View report >

Hepatitis Treatment Market and HIV AIDS Statistics in Africa

  • June 2017
    8 pages
  • Hepatitis Treat...  

    HIV AIDS  

  • Africa  

View report >

Related Market Segments :

Hepatitis Treatment
Antiviral

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.